Concomitant administration of drugs known to decrease the systemic availability of gatifloxacin.
Bowes
Jennifer
J
Department of Pharmacy, State University of New York-Upstate Medical University Hospital, Syracuse 13210, USA. bowesj@upstate.edu
Graffunder
Eileen M
EM
Lomaestro
Ben
B
Venezia
Richard A
RA
D000863:Antacids / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D019587:Dietary Supplements / Q000009:adverse effects; D004347:Drug Interactions; D024841:Fluoroquinolones; D000077734:Gatifloxacin; D006801:Humans; D012189:Retrospective Studies
D000863:Antacids; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D000077734:Gatifloxacin